Technical Analysis for MNK - Mallinckrodt plc

Grade Last Price % Change Price Change
grade F 20.43 2.66% 0.53
MNK closed down 0.55 percent on Thursday, January 17, 2019, on 74 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical MNK trend table...

Date Alert Name Type % Chg
Jan 17 Multiple of Ten Bearish Other 2.66%
Jan 17 Weak + Overbought Other 2.66%
Jan 17 Wide Bands Range Expansion 2.66%
Jan 17 Overbought Stochastic Strength 2.66%
Jan 16 Death Cross Bearish 2.10%
Jan 16 Multiple of Ten Bullish Other 2.10%
Jan 16 Weak + Overbought Other 2.10%
Jan 16 Wide Bands Range Expansion 2.10%
Jan 16 Overbought Stochastic Strength 2.10%
Jan 15 Narrow Range Bar Range Contraction 2.41%

Older signals for MNK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide. The company's Specialty Pharmaceuticals segment offers EXALGO extended-release tablets to treat pain in opioid-tolerant patients; and GABLOFEN injections indicated for use in the management of spasticity of cerebral or spinal origin in patients age four years and above. This segment also provides generic drugs, such as oxycodone or in combination with acetaminophen, as well as hydrocodone, which in combination with acetaminophen to treat pain; and methylphenidate to treat attention deficit hyperactivity disorder. This segment markets its branded products to physicians, including pain specialists, anesthesiologists, orthopedic surgeons, rheumatologists, and neurologists; and generic products to wholesalers, large- and medium-sized retail pharmacy chains, food store chains with pharmacies, mail order pharmacies, and other channels of distribution. Its Global Medical Imaging segment provides contrast media and delivery systems comprising iodine- and gadolinium-containing injectable products for diagnostic imaging applications, such as computed tomography and magnetic resonance imaging under the Optiray and Optimark brand names. This segment also offers nuclear imaging agents consisting of Technescan MAG3, a nuclear imaging agent to detect and evaluate a range of renal disorders; technetium-99m for use in Ultra-Technekow DTE generators; cold kits; and other radiopharmaceuticals, such as Octreoscan to detect cancer. This segment sells its contrast media systems to hospitals and hospital groups; branded products directly to managed care organizations; and API products to other pharmaceutical companies. The company was incorporated in 2013 and is based in Dublin, Ireland. Mallinckrodt plc (NYSE:MNK) operates independently of Covidien plc as of June 28, 2013.
Is MNK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.65
52 Week Low 11.65
Average Volume 2,497,234
200-Day Moving Average 22.7946
50-Day Moving Average 22.4908
20-Day Moving Average 17.9055
10-Day Moving Average 19.368
Average True Range 1.0541
ADX 29.03
+DI 24.4275
-DI 20.4055
Chandelier Exit (Long, 3 ATRs ) 17.3977
Chandelier Exit (Short, 3 ATRs ) 18.3423
Upper Bollinger Band 21.2513
Lower Bollinger Band 14.5597
Percent B (%b) 0.8
BandWidth 37.371757
MACD Line -0.3548
MACD Signal Line -0.9894
MACD Histogram 0.6345
Fundamentals Value
Market Cap 1.93 Billion
Num Shares 97 Million
EPS -4.63
Price-to-Earnings (P/E) Ratio -4.30
Price-to-Sales 0.92
Price-to-Book 0.59
PEG Ratio 0.79
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.16
Resistance 3 (R3) 21.17 20.77 20.95
Resistance 2 (R2) 20.77 20.45 20.76 20.88
Resistance 1 (R1) 20.33 20.25 20.13 20.32 20.81
Pivot Point 19.93 19.93 19.83 19.92 19.93
Support 1 (S1) 19.49 19.61 19.29 19.48 18.99
Support 2 (S2) 19.09 19.41 19.08 18.92
Support 3 (S3) 18.65 19.09 18.85
Support 4 (S4) 18.64